相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeted Protein Degradation via Lysosomes
Rishi R. Paudel et al.
BIOCHEMISTRY (2023)
Huntington's Disease: New Frontiers in Therapeutics
Ling Pan et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2021)
Single-Nucleus RNA-Seq Reveals Dysregulation of Striatal Cell Identity Due to Huntington's Disease Mutations
Sonia Malaiya et al.
JOURNAL OF NEUROSCIENCE (2021)
Double setback for ASO trials in Huntington disease
Katie Kingwell
NATURE REVIEWS DRUG DISCOVERY (2021)
Widespread and sustained target engagement in Huntington's disease minipigs upon intrastriatal microRNA-based gene therapy
Astrid Valles et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
TBN improves motor function and prolongs survival in a TDP-43M337V mouse model of ALS
Chunhui Huang et al.
HUMAN MOLECULAR GENETICS (2021)
Ensembl 2021
Kevin L. Howe et al.
NUCLEIC ACIDS RESEARCH (2021)
Optimizing intracellular antibodies (intrabodies/nanobodies) to treat neurodegenerative disorders
Anne Messer et al.
NEUROBIOLOGY OF DISEASE (2020)
Nanoscopic Insights of Amphiphilic Peptide against the Oligomer Assembly Process to Treat Huntington's Disease
Ruei-Yu He et al.
ADVANCED SCIENCE (2020)
Truncation of mutant huntingtin in knock-in mice demonstrates exon1 huntingtin is a key pathogenic form
Huiming Yang et al.
NATURE COMMUNICATIONS (2020)
Traffic signaling: new functions of huntingtin and axonal transport in neurological disease
Helene Vitet et al.
CURRENT OPINION IN NEUROBIOLOGY (2020)
TBtools: An Integrative Toolkit Developed for Interactive Analyses of Big Biological Data
Chengjie Chen et al.
MOLECULAR PLANT (2020)
Lysosome-targeting chimaeras for degradation of extracellular proteins
Steven M. Banik et al.
NATURE (2020)
AAV5-miHTT Gene Therapy Demonstrates Sustained Huntingtin Lowering and Functional Improvement in Huntington Disease Mouse Models
Elisabeth A. Spronck et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice
William A. Liguore et al.
MOLECULAR THERAPY (2019)
Targeting tauopathy with engineered tau-degrading intrabodies
Gilbert Gallardo et al.
MOLECULAR NEURODEGENERATION (2019)
Allele-selective lowering of mutant HTT protein by HTT-LC3 linker compounds
Zhaoyang Li et al.
NATURE (2019)
Huntington's disease: a clinical review
P. McColgan et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Cancer: From Wild-Type to Mutant Huntingtin
Morgane Sonia Thion et al.
JOURNAL OF HUNTINGTONS DISEASE (2018)
CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease
Su Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems
Ken Y. Chan et al.
NATURE NEUROSCIENCE (2017)
Pathway choice between proteasomal and autophagic degradation
Kefeng Lu et al.
AUTOPHAGY (2017)
Mutant Huntingtin Impairs BDNF Release from Astrocytes by Disrupting Conversion of Rab3a-GTP into Rab3a-GDP
Yan Hong et al.
JOURNAL OF NEUROSCIENCE (2016)
A scFv antibody targeting common oligomeric epitope has potential for treating several amyloidoses
Jun Zha et al.
SCIENTIFIC REPORTS (2016)
StringTie enables improved reconstruction of a transcriptome from RNA-seq reads
Mihaela Pertea et al.
NATURE BIOTECHNOLOGY (2015)
Characterisation of immune cell function in fragment and full-length Huntington's disease mouse models
Ulrike Trager et al.
NEUROBIOLOGY OF DISEASE (2015)
Trimmomatic: a flexible trimmer for Illumina sequence data
Anthony M. Bolger et al.
BIOINFORMATICS (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
scFv Antibody: Principles and Clinical Application
Zuhaida Asra Ahmad et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Bifunctional Anti-Huntingtin Proteasome-Directed Intrabodies Mediate Efficient Degradation of Mutant Huntingtin Exon 1 Protein Fragments
David C. Butler et al.
PLOS ONE (2011)
Early or Late-Stage Anti-N-Terminal Huntingtin Intrabody Gene Therapy Reduces Pathological Features in B6.HDR6/1 Mice
Abigail Snyder-Keller et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2010)
Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein
Peter O. Bauer et al.
NATURE BIOTECHNOLOGY (2010)
Intrabody and Parkinson's disease
Chun Zhou et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
Intrabody Gene Therapy Ameliorates Motor, Cognitive, and Neuropathological Symptoms in Multiple Mouse Models of Huntington's Disease
Amber L. Southwell et al.
JOURNAL OF NEUROSCIENCE (2009)
Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms
Jennifer Bradford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Suppression of neuropil aggregates and neurological symptoms by an intracellular antibody implicates the cytoplasmic toxicity of mutant huntingtin
Chuan-En Wang et al.
JOURNAL OF CELL BIOLOGY (2008)
AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease
Nicholas R. Franich et al.
MOLECULAR THERAPY (2008)
EXTENSIVE EARLY MOTOR AND NON-MOTOR BEHAVIORAL DEFICITS ARE FOLLOWED BY STRIATAL NEURONAL LOSS IN KNOCK-IN HUNTINGTON'S DISEASE MICE
M. A. Hickey et al.
NEUROSCIENCE (2008)
The potential of intracellular antibodies for therapeutic targeting of protein-misfolding diseases
Alessio Cardinale et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits
M. DiFiglia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA
YL Wang et al.
NEUROSCIENCE RESEARCH (2005)
Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice
E Rodriguez-Lebron et al.
MOLECULAR THERAPY (2005)
Suppression of Huntington's disease pathology in Drosophila by human single-chain Fv antibodies
WJ Wolfgang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model
SQ Harper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Sleeping Beauty-mediated down-regulation of huntingtin expression by RNA interference
ZYJ Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats
LB Menalled et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2003)
Effects of intracellular expression of anti-huntingtin antibodies of various specificities on mutant huntingtin aggregation and toxicity
A Khoshnan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The selective vulnerability of nerve cells in Huntington's disease
KA Sieradzan et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2001)
Neurological abnormalities in a knock-in mouse model of Huntington's disease
CH Lin et al.
HUMAN MOLECULAR GENETICS (2001)
分享论文
